Answers are grounded in this paper and cite their sources.
This study examined the potential function and mechanism of Polygonatum cyrtonema polysaccharide (PCP) in alleviating high-fat diet -induced obesity in mice.Our results showed that high-dose PCP (PCP-H) significantly reduced body weight, blood lipid, and blood glucose levels in HFD-induced obese mice, whereas low-dose PCP (PCP-L) exhibited limited efficacy.Gut microbiota analysis revealed that PCP-H interventions significantly increased the relative abundance of beneficial bacteria, including Muribaculaceae, Bacteroides, and Alloprevotella, and decreased the relative abundance of pathogenic bacteria, such as Mucispirillum and Escherichia-Shigella, in HFD-fed obese mice.Additionally, PCP-H administration increased the levels of short-chain fatty acids (SCFAs) such as acetic acid, propionic acid and butyric acid, which were correlated with the regulatory effect of PCP-H on the microbiota composition.Furthermore, PCP-H downregulated the mRNA expression of TLR-4, TNF-, IL-1, and IL-6 in the intestines, resulting in attenuated intestinal inflammation.Moreover, PCP-H restored intestinal barrier function by upregulating the gene and protein expression levels of claudin-1, occludin and ZO-1, which in turn led to decreased serum levels of proinflammatory cytokines (e.g., TNF-, IL-1, and IL-6).Taken together, these findings indicate the effect of PCP-H on mitigating diet-induced obesity may be associated with elevated levels of SCFAs, decreased intestinal inflammation, and enhanced intestinal barrier function, potentially mediated through the regulation of gut microbiota.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: